Antidepressants are drugs used for the treatment of major depressive disorder and other conditions, including dysthymia, anxiety disorders, obsessive–compulsive disorder, eating disorders, chronic pain, neuropathic pain and, in some cases, dysmenorrhoea, snoring, migraine, attention-deficit hyperactivity disorder (ADHD), addiction, dependence, and sleep disorders. They may be prescribed alone or in combination with other medications.

The market is mainly driven by the significant applications of Anti-Depressant in various end use industries. The expanding demands from the Major Depressive Disorder, Obsessive-Compulsive Disorder, Generalized Anxiety Disorder and Panic Disorder, are propelling Anti-Depressant market. Tricyclic Antidepressants, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Selective Serotonin Reuptake Inhibitors segment is estimated at % CAGR for the next seven-year period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Anti-Depressant, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Anti-Depressant market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Anti-Depressant market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Anti-Depressant sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Anti-Depressant covered in this report include Alkermes, Allergan, Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, Lundbeck, Merck, Pfizer and Teva Pharmaceutical Industries, etc.

The global Anti-Depressant market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

Alkermes

Allergan

Bristol-Myers Squibb

Eli Lilly and Company

GlaxoSmithKline

Lundbeck

Merck

Pfizer

Teva Pharmaceutical Industries

Takeda Pharmaceutical

Scope of Anti-Depressant - Market Report

Report Metric	Details
Report Name	Anti-Depressant - Market
Forecasted market size in 2029	US$ 18090 million
CAGR	3.3%
Forecasted years	2023 - 2029
Global Anti-Depressant market, by region:	North America (U.S., Canada, Mexico) Europe (Germany, France, UK, Italy, etc.) Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.) South America (Brazil, etc.) Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Anti-Depressant market, Segment by Type:	Tricyclic Antidepressants Selective Serotonin Reuptake Inhibitors Serotonin-Norepinephrine Reuptake Inhibitors Monoamine Oxidase Inhibitors Serotonin Antagonist Reuptake Inhibitors Others
Global Anti-Depressant market, by Application	Major Depressive Disorder Obsessive-Compulsive Disorder Generalized Anxiety Disorder Panic Disorder Others
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Anti-Depressant manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Anti-Depressant in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.

FAQ for this report

What is the Anti-Depressant - Market size in 2029?

Ans: The Anti-Depressant - Market size in 2029 will be US$ 18090 million.

What are the Application segmentation covered in the Anti-Depressant - Market report?

Ans: The Applications covered in the Anti-Depressant - Market report are Major Depressive Disorder, Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder, Others

What are the Type segmentation covered in the Anti-Depressant - Market report?

Ans: The Types covered in the Anti-Depressant - Market report are Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, Monoamine Oxidase Inhibitors, Serotonin Antagonist, Reuptake Inhibitors, Others

1 Anti-Depressant Market Overview

1.1 Anti-Depressant Product Overview

1.2 Anti-Depressant Market Segment by Type

1.2.1 Tricyclic Antidepressants

1.2.2 Selective Serotonin Reuptake Inhibitors

1.2.3 Serotonin-Norepinephrine Reuptake Inhibitors

1.2.4 Monoamine Oxidase Inhibitors

1.2.5 Serotonin Antagonist

1.2.6 Reuptake Inhibitors

1.2.7 Others

1.3 Global Anti-Depressant Market Size by Type

1.3.1 Global Anti-Depressant Market Size Overview by Type (2018-2029)

1.3.2 Global Anti-Depressant Historic Market Size Review by Type (2018-2023)

1.3.3 Global Anti-Depressant Forecasted Market Size by Type (2024-2029)

1.4 Key Regions Market Size Segment by Type

1.4.1 North America Anti-Depressant Sales Breakdown by Type (2018-2023)

1.4.2 Europe Anti-Depressant Sales Breakdown by Type (2018-2023)

1.4.3 Asia-Pacific Anti-Depressant Sales Breakdown by Type (2018-2023)

1.4.4 Latin America Anti-Depressant Sales Breakdown by Type (2018-2023)

1.4.5 Middle East and Africa Anti-Depressant Sales Breakdown by Type (2018-2023)

2 Global Anti-Depressant Market Competition by Company

2.1 Global Top Players by Anti-Depressant Sales (2018-2023)

2.2 Global Top Players by Anti-Depressant Revenue (2018-2023)

2.3 Global Top Players by Anti-Depressant Price (2018-2023)

2.4 Global Top Manufacturers Anti-Depressant Manufacturing Base Distribution, Sales Area, Product Type

2.5 Anti-Depressant Market Competitive Situation and Trends

2.5.1 Anti-Depressant Market Concentration Rate (2018-2023)

2.5.2 Global 5 and 10 Largest Manufacturers by Anti-Depressant Sales and Revenue in 2022

2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-Depressant as of 2022)

2.7 Date of Key Manufacturers Enter into Anti-Depressant Market

2.8 Key Manufacturers Anti-Depressant Product Offered

2.9 Mergers & Acquisitions, Expansion

3 Anti-Depressant Status and Outlook by Region

3.1 Global Anti-Depressant Market Size and CAGR by Region: 2018 VS 2022 VS 2029

3.2 Global Anti-Depressant Historic Market Size by Region

3.2.1 Global Anti-Depressant Sales in Volume by Region (2018-2023)

3.2.2 Global Anti-Depressant Sales in Value by Region (2018-2023)

3.2.3 Global Anti-Depressant Sales (Volume & Value) Price and Gross Margin (2018-2023)

3.3 Global Anti-Depressant Forecasted Market Size by Region

3.3.1 Global Anti-Depressant Sales in Volume by Region (2024-2029)

3.3.2 Global Anti-Depressant Sales in Value by Region (2024-2029)

3.3.3 Global Anti-Depressant Sales (Volume & Value), Price and Gross Margin (2024-2029)

4 Global Anti-Depressant by Application

4.1 Anti-Depressant Market Segment by Application

4.1.1 Major Depressive Disorder

4.1.2 Obsessive-Compulsive Disorder

4.1.3 Generalized Anxiety Disorder

4.1.4 Panic Disorder

4.1.5 Others

4.2 Global Anti-Depressant Market Size by Application

4.2.1 Global Anti-Depressant Market Size Overview by Application (2018-2029)

4.2.2 Global Anti-Depressant Historic Market Size Review by Application (2018-2023)

4.2.3 Global Anti-Depressant Forecasted Market Size by Application (2024-2029)

4.3 Key Regions Market Size Segment by Application

4.3.1 North America Anti-Depressant Sales Breakdown by Application (2018-2023)

4.3.2 Europe Anti-Depressant Sales Breakdown by Application (2018-2023)

4.3.3 Asia-Pacific Anti-Depressant Sales Breakdown by Application (2018-2023)

4.3.4 Latin America Anti-Depressant Sales Breakdown by Application (2018-2023)

4.3.5 Middle East and Africa Anti-Depressant Sales Breakdown by Application (2018-2023)

5 North America Anti-Depressant by Country

5.1 North America Anti-Depressant Historic Market Size by Country

5.1.1 North America Anti-Depressant Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

5.1.2 North America Anti-Depressant Sales in Volume by Country (2018-2023)

5.1.3 North America Anti-Depressant Sales in Value by Country (2018-2023)

5.2 North America Anti-Depressant Forecasted Market Size by Country

5.2.1 North America Anti-Depressant Sales in Volume by Country (2024-2029)

5.2.2 North America Anti-Depressant Sales in Value by Country (2024-2029)

6 Europe Anti-Depressant by Country

6.1 Europe Anti-Depressant Historic Market Size by Country

6.1.1 Europe Anti-Depressant Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

6.1.2 Europe Anti-Depressant Sales in Volume by Country (2018-2023)

6.1.3 Europe Anti-Depressant Sales in Value by Country (2018-2023)

6.2 Europe Anti-Depressant Forecasted Market Size by Country

6.2.1 Europe Anti-Depressant Sales in Volume by Country (2024-2029)

6.2.2 Europe Anti-Depressant Sales in Value by Country (2024-2029)

7 Asia-Pacific Anti-Depressant by Region

7.1 Asia-Pacific Anti-Depressant Historic Market Size by Region

7.1.1 Asia-Pacific Anti-Depressant Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029

7.1.2 Asia-Pacific Anti-Depressant Sales in Volume by Region (2018-2023)

7.1.3 Asia-Pacific Anti-Depressant Sales in Value by Region (2018-2023)

7.2 Asia-Pacific Anti-Depressant Forecasted Market Size by Region

7.2.1 Asia-Pacific Anti-Depressant Sales in Volume by Region (2024-2029)

7.2.2 Asia-Pacific Anti-Depressant Sales in Value by Region (2024-2029)

8 Latin America Anti-Depressant by Country

8.1 Latin America Anti-Depressant Historic Market Size by Country

8.1.1 Latin America Anti-Depressant Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

8.1.2 Latin America Anti-Depressant Sales in Volume by Country (2018-2023)

8.1.3 Latin America Anti-Depressant Sales in Value by Country (2018-2023)

8.2 Latin America Anti-Depressant Forecasted Market Size by Country

8.2.1 Latin America Anti-Depressant Sales in Volume by Country (2024-2029)

8.2.2 Latin America Anti-Depressant Sales in Value by Country (2024-2029)

9 Middle East and Africa Anti-Depressant by Country

9.1 Middle East and Africa Anti-Depressant Historic Market Size by Country

9.1.1 Middle East and Africa Anti-Depressant Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

9.1.2 Middle East and Africa Anti-Depressant Sales in Volume by Country (2018-2023)

9.1.3 Middle East and Africa Anti-Depressant Sales in Value by Country (2018-2023)

9.2 Middle East and Africa Anti-Depressant Forecasted Market Size by Country

9.2.1 Middle East and Africa Anti-Depressant Sales in Volume by Country (2024-2029)

9.2.2 Middle East and Africa Anti-Depressant Sales in Value by Country (2024-2029)

10 Company Profiles

10.1 Alkermes

10.1.1 Alkermes Company Information

10.1.2 Alkermes Introduction and Business Overview

10.1.3 Alkermes Anti-Depressant Sales, Revenue and Gross Margin (2018-2023)

10.1.4 Alkermes Anti-Depressant Products Offered

10.1.5 Alkermes Recent Development

10.2 Allergan

10.2.1 Allergan Company Information

10.2.2 Allergan Introduction and Business Overview

10.2.3 Allergan Anti-Depressant Sales, Revenue and Gross Margin (2018-2023)

10.2.4 Allergan Anti-Depressant Products Offered

10.2.5 Allergan Recent Development

10.3 Bristol-Myers Squibb

10.3.1 Bristol-Myers Squibb Company Information

10.3.2 Bristol-Myers Squibb Introduction and Business Overview

10.3.3 Bristol-Myers Squibb Anti-Depressant Sales, Revenue and Gross Margin (2018-2023)

10.3.4 Bristol-Myers Squibb Anti-Depressant Products Offered

10.3.5 Bristol-Myers Squibb Recent Development

10.4 Eli Lilly and Company

10.4.1 Eli Lilly and Company Company Information

10.4.2 Eli Lilly and Company Introduction and Business Overview

10.4.3 Eli Lilly and Company Anti-Depressant Sales, Revenue and Gross Margin (2018-2023)

10.4.4 Eli Lilly and Company Anti-Depressant Products Offered

10.4.5 Eli Lilly and Company Recent Development

10.5 GlaxoSmithKline

10.5.1 GlaxoSmithKline Company Information

10.5.2 GlaxoSmithKline Introduction and Business Overview

10.5.3 GlaxoSmithKline Anti-Depressant Sales, Revenue and Gross Margin (2018-2023)

10.5.4 GlaxoSmithKline Anti-Depressant Products Offered

10.5.5 GlaxoSmithKline Recent Development

10.6 Lundbeck

10.6.1 Lundbeck Company Information

10.6.2 Lundbeck Introduction and Business Overview

10.6.3 Lundbeck Anti-Depressant Sales, Revenue and Gross Margin (2018-2023)

10.6.4 Lundbeck Anti-Depressant Products Offered

10.6.5 Lundbeck Recent Development

10.7 Merck

10.7.1 Merck Company Information

10.7.2 Merck Introduction and Business Overview

10.7.3 Merck Anti-Depressant Sales, Revenue and Gross Margin (2018-2023)

10.7.4 Merck Anti-Depressant Products Offered

10.7.5 Merck Recent Development

10.8 Pfizer

10.8.1 Pfizer Company Information

10.8.2 Pfizer Introduction and Business Overview

10.8.3 Pfizer Anti-Depressant Sales, Revenue and Gross Margin (2018-2023)

10.8.4 Pfizer Anti-Depressant Products Offered

10.8.5 Pfizer Recent Development

10.9 Teva Pharmaceutical Industries

10.9.1 Teva Pharmaceutical Industries Company Information

10.9.2 Teva Pharmaceutical Industries Introduction and Business Overview

10.9.3 Teva Pharmaceutical Industries Anti-Depressant Sales, Revenue and Gross Margin (2018-2023)

10.9.4 Teva Pharmaceutical Industries Anti-Depressant Products Offered

10.9.5 Teva Pharmaceutical Industries Recent Development

10.10 Takeda Pharmaceutical

10.10.1 Takeda Pharmaceutical Company Information

10.10.2 Takeda Pharmaceutical Introduction and Business Overview

10.10.3 Takeda Pharmaceutical Anti-Depressant Sales, Revenue and Gross Margin (2018-2023)

10.10.4 Takeda Pharmaceutical Anti-Depressant Products Offered

10.10.5 Takeda Pharmaceutical Recent Development

11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis

11.1 Anti-Depressant Key Raw Materials

11.1.1 Key Raw Materials

11.1.2 Key Raw Materials Price

11.1.3 Raw Materials Key Suppliers

11.2 Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Anti-Depressant Industrial Chain Analysis

11.4 Anti-Depressant Market Dynamics

11.4.1 Anti-Depressant Industry Trends

11.4.2 Anti-Depressant Market Drivers

11.4.3 Anti-Depressant Market Challenges

11.4.4 Anti-Depressant Market Restraints

12 Market Strategy Analysis, Distributors

12.1 Sales Channel

12.2 Anti-Depressant Distributors

12.3 Anti-Depressant Downstream Customers

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.2 Data Source

14.2 Author Details

14.3 Disclaimer

FEATURED COMPANIES

Alkermes plc

Allergan plc

Bristol–Myers Squibb

Eli Lilly and Company

Teva Pharmaceutical Industries

Takeda Pharmaceutical

List of Tables

Table 1. Major Company of Tricyclic Antidepressants

Table 2. Major Company of Selective Serotonin Reuptake Inhibitors

Table 3. Major Company of Serotonin-Norepinephrine Reuptake Inhibitors

Table 4. Major Company of Monoamine Oxidase Inhibitors

Table 5. Major Company of Serotonin Antagonist

Table 6. Major Company of Reuptake Inhibitors

Table 7. Major Company of Others

Table 8. Global Anti-Depressant Sales by Type 2018 VS 2022 VS 2029 (US$ Million)

Table 9. Global Anti-Depressant Sales by Type (2018-2023) & (K Units)

Table 10. Global Anti-Depressant Sales Market Share in Volume by Type (2018-2023)

Table 11. Global Anti-Depressant Sales by Type (2018-2023) & (US& Million)

Table 12. Global Anti-Depressant Market Share in Value by Type (2018-2023)

Table 13. Global Anti-Depressant Price by Type (2018-2023) & (USD/Unit)

Table 14. Global Anti-Depressant Sales by Type (2024-2029) & (K Units)

Table 15. Global Anti-Depressant Sales Market Share in Volume by Type (2024-2029)

Table 16. Global Anti-Depressant Sales by Type (2024-2029) & (US$ Million)

Table 17. Global Anti-Depressant Sales Market Share in Value by Type (2024-2029)

Table 18. Global Anti-Depressant Price by Type (2024-2029) & (USD/Unit)

Table 19. North America Anti-Depressant Sales by Type (2018-2023) & (K Units)

Table 20. North America Anti-Depressant Sales by Type (2018-2023) & (US$ Million)

Table 21. Europe Anti-Depressant Sales (K Units) by Type (2018-2023)

Table 22. Europe Anti-Depressant Sales by Type (2018-2023) & (US$ Million)

Table 23. Asia-Pacific Anti-Depressant Sales (K Units) by Type (2018-2023)

Table 24. Asia-Pacific Anti-Depressant Sales by Type (2018-2023) & (US$ Million)

Table 25. Latin America Anti-Depressant Sales (K Units) by Type (2018-2023)

Table 26. Latin America Anti-Depressant Sales by Type (2018-2023) & (US$ Million)

Table 27. Middle East and Africa Anti-Depressant Sales (K Units) by Type (2018-2023)

Table 28. Middle East and Africa Anti-Depressant Sales by Type (2018-2023) & (US$ Million)

Table 29. Global Anti-Depressant Sales by Company (2018-2023) & (K Units)

Table 30. Global Anti-Depressant Sales Share by Company (2018-2023)

Table 31. Global Anti-Depressant Revenue by Company (2018-2023) & (US$ Million)

Table 32. Global Anti-Depressant Revenue Share by Company (2018-2023)

Table 33. Global Market Anti-Depressant Price by Company (2018-2023) & (USD/Unit)

Table 34. Global Anti-Depressant Top Manufacturers Manufacturing Base Distribution and Sales Area

Table 35. Global Anti-Depressant Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 36. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-Depressant as of 2022)

Table 37. Date of Key Manufacturers Enter into Anti-Depressant Market

Table 38. Key Manufacturers Anti-Depressant Product Type

Table 39. Mergers & Acquisitions, Expansion Plans

Table 40. Global Anti-Depressant Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029

Table 41. Global Anti-Depressant Sales by Region (2018-2023) & (K Units)

Table 42. Global Anti-Depressant Sales Market Share in Volume by Region (2018-2023)

Table 43. Global Anti-Depressant Sales by Region (2018-2023) & (US$ Million)

Table 44. Global Anti-Depressant Sales Market Share in Value by Region (2018-2023)

Table 45. Global Anti-Depressant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 46. Global Anti-Depressant Sales by Region (2024-2029) & (K Units)

Table 47. Global Anti-Depressant Sales Market Share in Volume by Region (2024-2029)

Table 48. Global Anti-Depressant Sales by Region (2024-2029) & (US$ Million)

Table 49. Global Anti-Depressant Sales Market Share in Value by Region (2024-2029)

Table 50. Global Anti-Depressant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2029)

Table 51. Global Anti-Depressant Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)

Table 52. Global Anti-Depressant Sales by Application (2018-2023) & (K Units)

Table 53. Global Anti-Depressant Sales Market Share in Volume by Application (2018-2023)

Table 54. Global Anti-Depressant Sales by Application (2018-2023) & (US$ Million)

Table 55. Global Anti-Depressant Sales Market Share in Value by Application (2018-2023)

Table 56. Global Anti-Depressant Price by Application (2018-2023) & (USD/Unit)

Table 57. Global Anti-Depressant Sales by Application (2024-2029) & (K Units)

Table 58. Global Anti-Depressant Sales Market Share in Volume by Application (2024-2029)

Table 59. Global Anti-Depressant Sales by Application (2024-2029) & (US$ Million)

Table 60. Global Anti-Depressant Sales Market Share in Value by Application (2024-2029)

Table 61. Global Anti-Depressant Price by Application (2024-2029) & (USD/Unit)

Table 62. North America Anti-Depressant Sales by Application (2018-2023) (K Units)

Table 63. North America Anti-Depressant Sales by Application (2018-2023) & (US$ Million)

Table 64. Europe Anti-Depressant Sales by Application (2018-2023) (K Units)

Table 65. Europe Anti-Depressant Sales by Application (2018-2023) & (US$ Million)

Table 66. Asia-Pacific Anti-Depressant Sales by Application (2018-2023) (K Units)

Table 67. Asia-Pacific Anti-Depressant Sales by Application (2018-2023) & (US$ Million)

Table 68. Latin America Anti-Depressant Sales by Application (2018-2023) (K Units)

Table 69. Latin America Anti-Depressant Sales by Application (2018-2023) & (US$ Million)

Table 70. Middle East and Africa Anti-Depressant Sales by Application (2018-2023) (K Units)

Table 71. Middle East and Africa Anti-Depressant Sales by Application (2018-2023) & (US$ Million)

Table 72. North America Anti-Depressant Sales by Country (2018-2023) & (K Units)

Table 73. North America Anti-Depressant Sales Market Share in Volume by Country (2018-2023)

Table 74. North America Anti-Depressant Sales by Country (2018-2023) & (US$ Million)

Table 75. North America Anti-Depressant Sales Market Share in Value by Country (2018-2023)

Table 76. North America Anti-Depressant Sales by Country (2024-2029) & (K Units)

Table 77. North America Anti-Depressant Sales Market Share in Volume by Country (2024-2029)

Table 78. North America Anti-Depressant Sales by Country (2024-2029) & (US$ Million)

Table 79. North America Anti-Depressant Sales Market Share in Value by Country (2024-2029)

Table 80. Europe Anti-Depressant Sales by Country (2018-2023) & (K Units)

Table 81. Europe Anti-Depressant Sales Market Share in Volume by Country (2018-2023)

Table 82. Europe Anti-Depressant Sales by Country (2018-2023) & (US$ Million)

Table 83. Europe Anti-Depressant Sales Market Share in Value by Country (2018-2023)

Table 84. Europe Anti-Depressant Sales by Country (2024-2029) & (K Units)

Table 85. Europe Anti-Depressant Sales Market Share in Volume by Country (2024-2029)

Table 86. Europe Anti-Depressant Sales by Country (2024-2029) & (US$ Million)

Table 87. Europe Anti-Depressant Sales Market Share in Value by Country (2024-2029)

Table 88. Asia-Pacific Anti-Depressant Sales by Region (2018-2023) & (K Units)

Table 89. Asia-Pacific Anti-Depressant Sales Market Share in Volume by Region (2018-2023)

Table 90. Asia-Pacific Anti-Depressant Sales by Region (2018-2023) & (US$ Million)

Table 91. Asia-Pacific Anti-Depressant Sales Market Share in Value by Region (2018-2023)

Table 92. Asia-Pacific Anti-Depressant Sales by Region (2024-2029) & (K Units)

Table 93. Asia-Pacific Anti-Depressant Sales Market Share in Volume by Region (2024-2029)

Table 94. Asia-Pacific Anti-Depressant Sales by Region (2024-2029) & (US$ Million)

Table 95. Asia-Pacific Anti-Depressant Sales Market Share in Value by Region (2024-2029)

Table 96. Latin America Anti-Depressant Sales by Country (2018-2023) & (K Units)

Table 97. Latin America Anti-Depressant Sales Market Share in Volume by Country (2018-2023)

Table 98. Latin America Anti-Depressant Sales by Country (2018-2023) & (US$ Million)

Table 99. Latin America Anti-Depressant Sales Market Share in Value by Country (2018-2023)

Table 100. Latin America Anti-Depressant Sales by Country (2024-2029) & (K Units)

Table 101. Latin America Anti-Depressant Sales Market Share in Volume by Country (2024-2029)

Table 102. Latin America Anti-Depressant Sales by Country (2024-2029) & (US$ Million)

Table 103. Latin America Anti-Depressant Sales Market Share in Value by Country (2024-2029)

Table 104. Middle East and Africa Anti-Depressant Sales by Country (2018-2023) & (K Units)

Table 105. Middle East and Africa Anti-Depressant Sales Market Share in Volume by Country (2018-2023)

Table 106. Middle East and Africa Anti-Depressant Sales by Country (2018-2023) & (US$ Million)

Table 107. Middle East and Africa Anti-Depressant Sales Market Share in Value by Country (2018-2023)

Table 108. Middle East and Africa Anti-Depressant Sales by Country (2024-2029) & (K Units)

Table 109. Middle East and Africa Anti-Depressant Sales Market Share in Volume by Country (2024-2029)

Table 110. Middle East and Africa Anti-Depressant Sales by Country (2024-2029) & (US$ Million)

Table 111. Middle East and Africa Anti-Depressant Sales Market Share in Value by Country (2024-2029)

Table 112. Alkermes Company Information

Table 113. Alkermes Introduction and Business Overview

Table 114. Alkermes Anti-Depressant Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 115. Alkermes Anti-Depressant Product

Table 116. Alkermes Recent Development

Table 117. Allergan Company Information

Table 118. Allergan Introduction and Business Overview

Table 119. Allergan Anti-Depressant Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 120. Allergan Anti-Depressant Product

Table 121. Allergan Recent Development

Table 122. Bristol-Myers Squibb Company Information

Table 123. Bristol-Myers Squibb Introduction and Business Overview

Table 124. Bristol-Myers Squibb Anti-Depressant Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 125. Bristol-Myers Squibb Anti-Depressant Product

Table 126. Bristol-Myers Squibb Recent Development

Table 127. Eli Lilly and Company Company Information

Table 128. Eli Lilly and Company Introduction and Business Overview

Table 129. Eli Lilly and Company Anti-Depressant Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 130. Eli Lilly and Company Anti-Depressant Product

Table 131. Eli Lilly and Company Recent Development

Table 132. GlaxoSmithKline Company Information

Table 133. GlaxoSmithKline Introduction and Business Overview

Table 134. GlaxoSmithKline Anti-Depressant Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 135. GlaxoSmithKline Anti-Depressant Product

Table 136. GlaxoSmithKline Recent Development

Table 137. Lundbeck Company Information

Table 138. Lundbeck Introduction and Business Overview

Table 139. Lundbeck Anti-Depressant Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 140. Lundbeck Anti-Depressant Product

Table 141. Lundbeck Recent Development

Table 142. Merck Company Information

Table 143. Merck Introduction and Business Overview

Table 144. Merck Anti-Depressant Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 145. Merck Anti-Depressant Product

Table 146. Merck Recent Development

Table 147. Pfizer Company Information

Table 148. Pfizer Introduction and Business Overview

Table 149. Pfizer Anti-Depressant Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 150. Pfizer Anti-Depressant Product

Table 151. Pfizer Recent Development

Table 152. Teva Pharmaceutical Industries Company Information

Table 153. Teva Pharmaceutical Industries Introduction and Business Overview

Table 154. Teva Pharmaceutical Industries Anti-Depressant Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 155. Teva Pharmaceutical Industries Anti-Depressant Product

Table 156. Teva Pharmaceutical Industries Recent Development

Table 157. Takeda Pharmaceutical Company Information

Table 158. Takeda Pharmaceutical Introduction and Business Overview

Table 159. Takeda Pharmaceutical Anti-Depressant Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 160. Takeda Pharmaceutical Anti-Depressant Product

Table 161. Takeda Pharmaceutical Recent Development

Table 162. Key Raw Materials Lists

Table 163. Raw Materials Key Suppliers Lists

Table 164. Anti-Depressant Market Trends

Table 165. Anti-Depressant Market Drivers

Table 166. Anti-Depressant Market Challenges

Table 167. Anti-Depressant Market Restraints

Table 168. Anti-Depressant Distributors List

Table 169. Anti-Depressant Downstream Customers

Table 170. Research Programs/Design for This Report

Table 171. Key Data Information from Secondary Sources

Table 172. Key Data Information from Primary Sources

List of Figures

Figure 1. Anti-Depressant Product Picture

Figure 2. Global Anti-Depressant Market Size, 2018 VS 2022 VS 2029 (US$ Million)

Figure 3. Global Anti-Depressant Market Size Status and Outlook (2018-2029) & (US$ Million)

Figure 4. Global Anti-Depressant Sales Status and Outlook (2018-2029) & (K Units)

Figure 5. Product Picture of Tricyclic Antidepressants

Figure 6. Global Tricyclic Antidepressants Sales YoY Growth (2018-2029) & (K Units)

Figure 7. Product Picture of Selective Serotonin Reuptake Inhibitors

Figure 8. Global Selective Serotonin Reuptake Inhibitors Sales YoY Growth (2018-2029) & (K Units)

Figure 9. Product Picture of Serotonin-Norepinephrine Reuptake Inhibitors

Figure 10. Global Serotonin-Norepinephrine Reuptake Inhibitors Sales YoY Growth (2018-2029) & (K Units)

Figure 11. Product Picture of Monoamine Oxidase Inhibitors

Figure 12. Global Monoamine Oxidase Inhibitors Sales YoY Growth (2018-2029) & (K Units)

Figure 13. Product Picture of Serotonin Antagonist

Figure 14. Global Serotonin Antagonist Sales YoY Growth (2018-2029) & (K Units)

Figure 15. Product Picture of Reuptake Inhibitors

Figure 16. Global Reuptake Inhibitors Sales YoY Growth (2018-2029) & (K Units)

Figure 17. Product Picture of Others

Figure 18. Global Others Sales YoY Growth (2018-2029) & (K Units)

Figure 19. Global Anti-Depressant Sales by Type (2018-2029) & (US$ Million)

Figure 20. Global Anti-Depressant Sales Market Share by Type in 2022 & 2029

Figure 21. North America Anti-Depressant Sales Market Share in Volume by Type in 2022

Figure 22. North America Anti-Depressant Sales Market Share in Value by Type in 2022

Figure 23. Europe Anti-Depressant Sales Market Share in Volume by Type in 2022

Figure 24. Europe Anti-Depressant Sales Market Share in Value by Type in 2022

Figure 25. Asia-Pacific Anti-Depressant Sales Market Share in Volume by Type in 2022

Figure 26. Asia-Pacific Anti-Depressant Sales Market Share in Value by Type in 2022

Figure 27. Latin America Anti-Depressant Sales Market Share in Volume by Type in 2022

Figure 28. Latin America Anti-Depressant Sales Market Share in Value by Type in 2022

Figure 29. Middle East and Africa Anti-Depressant Sales Market Share in Volume by Type in 2022

Figure 30. Middle East and Africa Anti-Depressant Sales Market Share in Value by Type in 2022

Figure 31. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti-Depressant Sales in 2022

Figure 32. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti-Depressant Revenue in 2022

Figure 33. Anti-Depressant Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022

Figure 34. Product Picture of Major Depressive Disorder

Figure 35. Global Major Depressive Disorder Sales YoY Growth (2018-2029) & (K Units)

Figure 36. Product Picture of Obsessive-Compulsive Disorder

Figure 37. Global Obsessive-Compulsive Disorder Sales YoY Growth (2018-2029) & (K Units)

Figure 38. Product Picture of Generalized Anxiety Disorder

Figure 39. Global Generalized Anxiety Disorder Sales YoY Growth (2018-2029) & (K Units)

Figure 40. Product Picture of Panic Disorder

Figure 41. Global Panic Disorder Sales YoY Growth (2018-2029) & (K Units)

Figure 42. Product Picture of Others

Figure 43. Global Others Sales YoY Growth (2018-2029) & (K Units)

Figure 44. Global Anti-Depressant Sales by Application (2018-2029) & (US$ Million)

Figure 45. Global Anti-Depressant Sales Market Share by Application in 2022 & 2029

Figure 46. North America Anti-Depressant Sales Market Share in Volume by Application in 2022

Figure 47. North America Anti-Depressant Sales Market Share in Value by Application in 2022

Figure 48. Europe Anti-Depressant Sales Market Share in Volume by Application in 2022

Figure 49. Europe Anti-Depressant Sales Market Share in Value by Application in 2022

Figure 50. Asia-Pacific Anti-Depressant Sales Market Share in Volume by Application in 2022

Figure 51. Asia-Pacific Anti-Depressant Sales Market Share in Value by Application in 2022

Figure 52. Latin America Anti-Depressant Sales Market Share in Volume by Application in 2022

Figure 53. Latin America Anti-Depressant Sales Market Share in Value by Application in 2022

Figure 54. Middle East and Africa Anti-Depressant Sales Market Share in Value by Application in 2022

Figure 55. Key Raw Materials Price

Figure 56. Anti-Depressant Manufacturing Cost Structure

Figure 57. Anti-Depressant Industrial Chain Analysis

Figure 58. Channels of Distribution

Figure 59. Distributors Profiles

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3350

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions